» Articles » PMID: 25960418

Medicare Managed Care Spillovers and Treatment Intensity

Overview
Journal Health Econ
Publisher Wiley
Date 2015 May 12
PMID 25960418
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Evidence suggests that the share of Medicare managed care enrollees in a region affects the costs of treating traditional fee-for-service (FFS) Medicare beneficiaries; however, little is known about the mechanisms through which these 'spillover effects' operate. This paper examines the relationship between Medicare managed care penetration and treatment intensity for FFS enrollees hospitalized with a primary diagnosis of AMI. I find that increased Medicare managed care penetration is associated with a reduction in both the costs and the treatment intensity of FFS AMI patients. Specifically, as Medicare managed care penetration increases, FFS AMI patients are less likely to receive surgical reperfusion and mechanical ventilation and to experience an overall reduction in the number of inpatient procedures. Copyright © 2015 John Wiley & Sons, Ltd.

Citing Articles

Spending Changes After Moving to Areas With Greater ACO Participation Among Nonattributed Medicare Beneficiaries.

Hou Y, Domino M, Lewis V, Gong Q, Callison K, Trogdon J JAMA Netw Open. 2025; 8(2):e2458311.

PMID: 39976969 PMC: 11843370. DOI: 10.1001/jamanetworkopen.2024.58311.


Primary Care Physicians In Medicare Advantage Were Less Costly, Provided Similar Quality Versus Regional Average.

Politzer E, Anderson T, Ayanian J, Curto V, Graves J, Hatfield L Health Aff (Millwood). 2024; 43(3):372-380.

PMID: 38437612 PMC: 11040031. DOI: 10.1377/hlthaff.2023.00803.


Association of Medicare Advantage vs Traditional Medicare With 30-Day Mortality Among Patients With Acute Myocardial Infarction.

Landon B, Anderson T, Curto V, Cram P, Fu C, Weinreb G JAMA. 2022; 328(21):2126-2135.

PMID: 36472594 PMC: 9856265. DOI: 10.1001/jama.2022.20982.


Measuring the Scope of Prior Authorization Policies: Applying Private Insurer Rules to Medicare Part B.

Schwartz A, Brennan T, Verbrugge D, Newhouse J JAMA Health Forum. 2022; 2(5):e210859.

PMID: 35977311 PMC: 8796979. DOI: 10.1001/jamahealthforum.2021.0859.


Trading spaces: Medicare's regulatory spillovers on treatment setting for non-Medicare patients.

Geruso M, Richards M J Health Econ. 2022; 84:102624.

PMID: 35580506 PMC: 10371213. DOI: 10.1016/j.jhealeco.2022.102624.